Supporting scientific progress to understand primary tauopathies in neurodegenerative disease research.
Visit our website to discover all our funding programs.
What can biomarkers reveal about PSP biology? Our own Glenn Harris, Ph.D., joined the @CurePSP Collective Minds Podcast to discuss our joint efforts exploring the future of biomarker-driven research.
Listen to the discussion here: https://t.co/cKsMGFLVJ2
Can we target tau before harmful pathology takes hold? Sprint to Lead awardee Dr. Markus Zweckstetter and his team are developing small molecules designed to stabilize healthy tau, an approach that could address tau-driven FTD & other primary tauopathies: https://t.co/nTVkyC8MQr
Can we change how cells produce tau, clear harmful tau, or prevent tau from becoming harmful in the first place? The inaugural Sprint to Lead awardees are pursuing all three, advancing promising ideas toward potential treatments for primary tauopathies. https://t.co/JJANGgVOgf
We’re proud to announce the first-ever Sprint to Lead awardees. Each of their teams are advancing new approaches to target, remove, or stabilize tau with the goal of accelerating future therapies.
Meet the awardees: https://t.co/awTng4mvdo
The next breakthrough in primary tauopathy research may come from AI uncovering hidden patterns in scientific data. Join the Tau Consortium Learning Research Network and help shape AI-enabled science. Letters of Intent are due Oct. 30: https://t.co/hzVeUeh8GI
We’re attending @CurePSP's PSP Research Roundtable, bringing together leaders from academia, industry, & advocacy organizations to address key bottlenecks & accelerate new treatments for PSP & other primary tauopathies. Learn more: https://t.co/3zi5pmQMrP
The @RCFNeuro has awarded $3 million in grants to fund four studies in its 2026 Tauopathy Challenge Workshop. Researchers will explore tau’s role in #neurodegenerative disorders characterized by #tau protein accumulation.
@alzassociation@CurePSP
https://t.co/bGNyqUuU5r
Progress happens faster when we work together. We’re proud to partner with and co-fund programs alongside @AFTDHope, @BluefieldProj, @CurePSP, and @FNIH_org to advance biomarker research in primary tauopathies. Learn more about our partnerships: https://t.co/TCmM54V0FZ
What if tau doesn’t look the same in every cell it affects? Dr. Edward Lee, a Tauopathy Challenge Workshop 2026 grantee, aims to visualize PSP-associated tau aggregates across cell environments to deepen our understanding of the disease: https://t.co/T2VuEdVNcF
Have an innovative idea that could advance brain health or dementia research in Texas?
BRING IT, a new initiative from @RCFNeuro and @alzassociation, will provide one-year seed grants of up to $100K to help Texas researchers accelerate promising research.
https://t.co/Kv0859QYmj
About a third of people with frontotemporal dementia are first misdiagnosed with a psychiatric condition.
Improving diagnostic accuracy is critical, and advances in biomarkers and genetics may help.
Learn more via @Being_Patient_: https://t.co/VBofNI9EDB
Introducing the Tau Consortium Learning Research Network, an AI-enabled research environment designed to help scientists advance primary tauopathy research and accelerate scientific discovery. Apply by Oct. 30: https://t.co/oZAekEb3yh
Every disease-associated tau structure begins with a set of molecular instructions. Dr. Sue-Ann Mok, a 2026 Tauopathy Challenge Workshop grantee, is working to decode them and identify signals that could interrupt tau aggregation. Learn about her research: https://t.co/biDbjlD7NM
For more than a decade, Dr. Daniel Lee has studied citrullination, an overlooked and irreversible modification of tau. As a 2026 Tauopathy Challenge Workshop grantee, he's investigating how it shapes disease biology and influences neurodegeneration: https://t.co/ysOAe00rEP
Dr. Carlo Condello, a Tauopathy Challenge Workshop grantee, is using new EMBER imaging to uncover distinct tau signatures across brain cell types. This work could inform future diagnostics and therapies for PSP and related tauopathies. Learn more: https://t.co/30X8TIj1tl
What are the molecular and cellular rules that shape tau-driven diseases? Four researchers were awarded grants to explore that question through distinct approaches to tau biology. Explore their work in our latest blog: https://t.co/QkFYqyqR13
Exciting news from the 2026 Tauopathy Challenge Workshop: Four researchers have been awarded a combined $3 million in grants to investigate the structural & thermodynamic properties of tau protein. Read more: https://t.co/8dGLQ8cqlu
@aging_mind@alzassociation@CurePSP
How do we better measure disease biology in Progressive Supranuclear Palsy (PSP)? Co-developed with @CurePSP , our new review examines the promise of multimodal biomarkers for advancing precision medicine in PSP and related tauopathies. Read more: https://t.co/yIGuuDiKdb
Tau pathology may reshape the brain beyond protein buildup. This research from inaugural Tauopathy Challenge Workshop grantee Dr. Rik van der Kant (@biomeettweet) found tau mutations disrupt lipid pathwaysdriving buildup and cholesterol dysfunction: https://t.co/5eruqNdv7b